Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003

Xspray Pharma publ AB

14/04/2026 15:11

April 14 (Reuters) - Xspray Pharma publ AB XSPRAY.ST:

FDA ACCEPTS TRADE NAME NILOPKI FOR XSPRAY'S DRUG CANDIDATE XS003 (NILOTINIB)

PLANS US LAUNCH OF NILOPKI AND DASYNOC IN SECOND HALF OF 2026

Source text: ID:nMFNzTcQh

Further company coverage: XSPRAY.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))